Bionomics News

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersOneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday's after-market session. The market value of their outstanding shares is at $44.8 million. Aesthetic Medical Intl (N

BenzingaApr 3 04:31

Buy Rating Affirmed for Bionomics' BNC210 Following Promising PTSD Study Results

TipRanksMar 28 00:45

Bionomics's BNC210 Shows Promise for PTSD Treatment: A Buy Rating Analysis

TipRanksMar 22 00:05

Bionomics Reveals Detailed Data From PTSD Trial, Stock Soars

Thursday, Bionomics Limited (NASDAQ:BNOX) released a full dataset analysis from its Phase 2b ATTUNE trial of BNC210 in patients with post-traumatic stress disorder (PTSD).In September 2023, Bionomics

BenzingaMar 21 21:36

Bionomics Reports Results of the Full Dataset Analysis From ATTUNE Phase 2b Trial of BNC210 in Patients With Post-Traumatic Stress Disorder

BNC210 demonstrated a statistically significant improvement in post-traumatic stress disorder (PTSD) symptom severity with a clinically meaningful effect size suggesting a potential advantage over approved medications.

GlobeNewswireMar 21 18:00

Global Post-traumatic Stress Disorder (PTSD) Drug Pipeline Landscape Report 2024 Featuring Tonix Pharmaceuticals, Pop Test Oncology, H. Lundbeck, Bionomics, and Alto Neuroscience

Yahoo FinanceMar 1 00:06

Bionomics to Present at the 2024 BIO CEO & Investor Conference

ADELAIDE, Australia and CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (NASDAQ:BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric

GlobeNewswireFeb 23 05:30

Ocugen, Community Health Systems Among Healthcare Movers

Seeking AlphaFeb 22 23:00

Bionomics: A Strong Buy on Clinical and Regulatory Milestones

TipRanksJan 23 03:47

Wall Street Set to Open Higher in Monday Trading Ahead of Economic Indicators Data

US stocks look set to open the week on a positive note, rising higher in Monday's premarket session higher ahead of the index of leading economic indicators for December that is to be released later i

MT NewswiresJan 22 22:06

XPEV, BILI and ROMA Among Pre-market Losers

Seeking AlphaJan 22 21:26

US Futures Poised to Open Week Higher, Leading Economic Indicators on Tap

US stock futures rose ahead of the index of leading economic indicators for December, which is slated for release at 10 a.m. ET and is forecast to be down 0.3%, according to Investing.com The Dow Jone

MT NewswiresJan 22 21:14

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersMSP Recovery (NASDAQ:LIFW) shares rose 23.1% to $1.49 during Monday's pre-market session. The market value of their outstanding shares is at $21.4 million. 60 Degrees (NASDAQ:SXTP) stock moved

BenzingaJan 22 21:05

Bionomics Provides a Review of 2023 and of 2024 Plans

Positive Phase 2b data announced for BNC210 on reduction of total symptom severity and multiple symptom clusters in post-traumatic stress disorder (PTSD), with a discussion with the U.S. Food & Drug Administration

GlobeNewswireJan 22 19:00

Bionomics to Present at Biotech Showcase 2024

ADELAIDE, Australia and CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (NASDAQ:BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric

GlobeNewswireJan 5 19:00

HC Wainwright & Co. Reiterates Buy on Bionomics, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Bionomics (NASDAQ:BNOX) with a Buy and maintains $8 price target.

BenzingaDec 7, 2023 19:38

Bionomics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/07/2023 504.18% HC Wainwright & Co. → $8 Reiterates Buy → Buy 09/28/2023 655.23% Maxim Group $7 → $10 M

BenzingaDec 7, 2023 19:37

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersReshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 17.9% to $0.31 during Wednesday's after-market session. The market value of their outstanding shares is at $4.0 million. Monopar Therap

BenzingaDec 7, 2023 05:31

Bionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting

A psychometric analysis concluded that Subjective Units of Distress Scale (SUDS) is a psychometrically valid, sensitive, and reliable tool for evaluation of social anxiety.SUDS will be used as the pri

GlobeNewswireDec 6, 2023 21:00

Penumbra, Verve Therapeutics Among Healthcare Movers

Seeking AlphaNov 13, 2023 23:00